Opinion of the High Council for Public Health regarding the minimum mandatory information for advertising the tetravalent meningococcal conjugate vaccine A, C, Y, W135 Menveo®.
Author(s): Haut Conseil de la Santé Publique
Publishing year: 2011
Pages: 151
Weekly Epidemiological Bulletin, 2011, n° 10-11, p. 151
In relation to
Our latest news
news
SIBCA 2026: The UrBaCS network presents its solutions for cities and...
news
Physical Activity and Combating a Sedentary Lifestyle: How Does Santé...
news
